Navigation Links
$10 million gift to support cutting-edge epigenome center at USC

Los Angeles, Oct. 2, 2007The Keck School of Medicine of the University of Southern California (USC) received a $10 million gift from the Kenneth T. & Eileen L. Norris Foundation that will be critical in launching one of the nations first research centers devoted to the study of epigenetics.

The grant will solidify USCs position at the forefront of epigenetics researcha field that holds great promise in the treatment and prevention of cancer, says Peter Jones, Ph.D., director of the USC/Norris Comprehensive Cancer Center at the Keck School.

This gift is critical to the university because of the large amount of epigenetics research that has already taken place at USC, Jones says. Weve been one of the leaders in the field for some time and the commitment of the Norris Foundation will allow us to expand our capabilities. We shall now be able to use high throughput techniques to sequence entire epigenomes for the first time. Such approaches would have been unthinkable even a short while ago.

Epigenetics is the study of how chemicals that attach to DNA and proteins can switch genes on and off without changing the fundamental genetic information. Understanding how specific genes switch on and off has vast implications for the prevention and treatment of cancer and other diseases. Jones, a past president of the American Association for Cancer Research, says he expects the Epigenome Center at USC will play an integral role in the international epigenome project he is spearheading.

Most of the research up to now has been focused on genetics, Jones says. Now, people are starting to realize that epigenetic processes that package the genome are critical to how it can be used in different cells. When the packaging is right, cells work. When it goes wrong disease can occur.

Ronald Barnes, executive director and trustee of the Kenneth T. & Eileen L. Norris Foundation, says he is pleased that the grant will help the university to meet the increasing demands for new, cutting-edge research.

We are proud to continue our support of the USC/Norris Comprehensive Cancer Center by helping to develop one of the first epigenome centers in the world, he says. We believe the facility will be critical to the future of cancer research.

Through its foundation, the Norris family has given more than $50 million to USC, naming the USC/Norris Comprehensive Cancer Center, the Eileen L. Norris Cinema Theater, the Norris Dental Center, the Norris Medical Library and the Norris Auditorium.

The Epigenome Center will be housed on the ground floor of the Harlyne J. Norris Cancer Research Tower, a 172,440 square-foot research facility that opened earlier this year at USCs Health Sciences Campus. The center will house state-of-the-art sequencing equipment and computational biologists who will analyze the massive amount of data to be produced. The $10 million gift will go towards acquisition of equipment and staff recruitment.

Peter Laird, a lead researcher and associate professor of surgery, biochemistry and molecular biology, has been named director of the center. A formal opening is planned for January 2008.

In the past year, the center has received five National Cancer Institute grants, five Foundation grants, two California Institute for Regenerative Medicine (CIRM) seed grants and three CIRM basic science grants.

The Norris Foundations support will position the university to apply for additional funding from the National Institutes of Health, which has launched a Roadmap Epigenetics Program, Jones notes. The program seeks to develop comprehensive reference epigenome maps and new technologies for comprehensive epigenomic analyses throughout the world.

The grant is a very generous and well-timed gift which allows USC and the Norris Comprehensive Cancer Center to continue its upward trajectory in this field. It contributes directly to the well being of people and patients, Jones says.


Contact: Meghan Lewit
University of Southern California

Related biology news :

1. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
2. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
3. Six million Africans face famine because of locusts, drought
4. Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans
5. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
6. $5.1 billion would save 6 million children
7. Health costs soar as 60 million Americans classed as obese
8. Malaria killing a million a year
9. $6.5 Million Grant for Microarray Center at Yale School of Medicine
10. TGen awarded $7.1 million to accelerate brain disease research
11. MSU researchers receive $4 million grant to uncover gene functions
Post Your Comments:
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
(Date:3/22/2016)... , March 22, 2016 ... report "Electronic Sensors Market for Consumer Industry by Type ... Others), Application (Communication & IT, Entertainment, Home ... Global Forecast to 2022", published by MarketsandMarkets, ... expected to reach USD 26.76 Billion by ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology: